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Commentary 
The article by Hiinerbein and associates describes the 
potential usefulness of endoscopic ultrasonography (EUS) 
with needle biopsy for the evaluation of mediastinal structures 
adjacent to the esophagus. Their experience mirrors my expe-
rience at the Medical University of South Carolina (MUSC). 
Although EUS is not yet a common procedure in many cen-
ters in the United States, I anticipate that its utility will 
increase as physicians recognize the clinical relevance and 
very minimally invasive nature of the procedure. EUS with 
biopsy does require gastroenterologists trained in the tech-
nique and close cooperation with the thoracic surgeons. 
At MUSC, my colleagues and I have used EUS and fine 
needle aspiration (FNA) to evaluate more than 140 patients 
with a lung mass and mediastinal adenopathy. The radi-
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ographically designated abnormal lymph nodes in both the 
aortopulmonary window and the subcarinal region are now 
preferentially evaluated by EUS/FNA. In the period from 
June 1994 to September 1997, 82 patients with a lung mass 
and mediastinal adenopathy underwent EUS/FNA. The sen-
sitivity for the diagnosis of malignancy was 88% and the 
specificity was 100%. More than 30 patients with abnormal 
mediastinal adenopathy without a dominant pUlmonary mass 
have also been evaluated by EUS/FNA. Similar to the find-
ings of Hiinerbein and colleagues, a variety of disease 
processes have been diagnosed, including sarcoidosis, histo-
plasmosis, lymphoma, and small cell lung cancer. 
Our experience has been confined to aspiration cytology. 
The development of a specialized needle that is capable of giv-
ing a core biopsy for histologic evaluation may be particularly 
helpful in cases of lymphoma and granulomatous disease. Like 
the authors, we have observed no complications from 
EUS/FNA. 
As a diagnostic and staging tool, EUS/FNA is meant to be 
a complementary procedure to cervical mediastinoscopy and 
thoracoscopy. In our hands, EUS/FNA is less invasive and 
more cost effective when applied to the correct situation. In 
my opinion, other reports will soon verify the results in the 
present article as surgeons become familiar with the potential 
usefulness of EUS-guided needle biopsy. 
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